Everolimus
NDC 51991-992, Everolimus, tablet, for suspension, from Breckenridge Pharmaceutical, Inc..
- Product NDC
- 51991-992
- Status
- Listed
- Labeler
- Breckenridge Pharmaceutical, Inc.
- Dosage form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217640
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51991-992 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EVEROLIMUS5 mg/1
Pharmacologic classes
Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51991-992-28 | 51991099228 | 4 BLISTER PACK in 1 CARTON (51991-992-28) / 7 TABLET, FOR SUSPENSION in 1 BLISTER PACK (51991-992-99) |
| 51991-992-77 | 51991099277 | 28 TABLET, FOR SUSPENSION in 1 BOTTLE (51991-992-77) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/01f7b5fb-be0d-4adf-acd2-6899018de966
Use it
Look up 51991-992 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51991-992 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51991-992. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.